CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$ (96,322)	$ (71,961)	$ (37,109)
Adjustments to reconcile net loss to net cash used by operating activities
Depreciation and amortization	4,262	463	295
Amortization of debt discount		14	8
Asset Impairment	4,441
Non-employee warrant expense	289	931	481
Provision for warranty expense	(784)	7,634	3,370
Loss on extinguishment of debt		27	164
Non-cash lease expense	1,405	621	461
Stock-based compensation related to acquisition	811	812	707
Stock-based compensation	12,905	7,319	1,052
Compensation expense related to acquisition	5,042		3,353
Change in fair value of earnout related to acquisition	310
Deferred tax benefit	(5,720)	(18)	21
Non-cash interest expense	107	11	100
Provision for excess and obsolete inventory	117	(39)	778
Provision for doubtful accounts	242	226	512
Change in operating assets and liabilities
Accounts receivable	(15,943)	(23,969)	(13,526)
Inventory	(42,811)	(15,778)	(11,090)
Deferred cost of revenue	(9,880)	(9,315)	(8,584)
Prepaid expenses and other assets	2,366	(11,284)	1,014
Accounts payable	12,446	3,811	(72)
Accrued expenses and other liabilities	3,243	1,605	(3,209)
Deferred revenue	43,691	38,945	32,841
Lease liabilities	(1,254)	(449)	(36)
Net cash used in operating activities	(81,037)	(70,376)	(28,490)
CASH FLOWS FROM INVESTING ACTIVITIES
Purchase of property and equipment	(1,113)	(1,471)	(298)
Payment for loan receivable		(2,000)
Net cash used in investing activities	(130,789)	(9,373)	(2,680)
CASH FLOWS FROM FINANCING ACTIVITIES
Payments from revolving line of credit			7,179
Payments on revolving line of credit			(11,981)
Payments on term loan		(4,861)	(139)
Payments of senior revolving facility transaction costs		(658)
Payments on note payable related to acquisition			(4,327)
Proceeds from warrant exercise	3	5
Proceeds from convertible notes			50
Proceeds from options exercise	186
Proceeds for ESPP purchases	1,125
Taxes paid related to net share settlements of stock-based compensation awards	(4,045)
Convertible preferred stock issued		35,000	57,500
Payments of convertible stock transaction costs		(207)	(61)
Proceeds from business combination and private offering		500,628
Payments for business combination and private offering transaction costs	(70)	(55,981)
Net cash (used in) provided by financing activities	(2,801)	473,926	48,221
Effect of exchange rate changes on cash and cash equivalents	(264)	(191)	143
Net (decrease) increase in cash, cash equivalents, and restricted cash	(214,891)	393,986	17,194
Cash, cash equivalents, and restricted cash - beginning of period	432,604	38,618	21,424
Cash, cash equivalents, and restricted cash - end of period	217,713	432,604	38,618
Reconciliation of cash, cash equivalents, and restricted cash to the consolidated balance sheets
Cash and cash equivalents	210,409	430,841	38,618
Restricted cash, current portion	7,057	1,268
Restricted cash, included in other long-term assets	247	495
Total cash, cash equivalents, and restricted cash	217,713	432,604	38,618
Supplemental disclosure of cash flow information
Interest paid	146	254	459
Cash paid for income taxes	197	14	83
Schedule of non-cash investing and financing activities
Accrued property and equipment at period end	110	25	32
Contingent consideration		5,230
Acquisition consideration held in escrow		1,021
Conversion of convertible debt to preferred stock			7,787
Common stock issued as consideration for acquisition			813
Conversion of convertible preferred stock to common stock		146,225
Zenith
CASH FLOWS FROM INVESTING ACTIVITIES
Acquisition, net of cash acquired			$ (2,382)
SightPlan
CASH FLOWS FROM INVESTING ACTIVITIES
Acquisition, net of cash acquired	$ (129,676)
iQuue
CASH FLOWS FROM INVESTING ACTIVITIES
Acquisition, net of cash acquired		$ (5,902)